By a News Reporter-Staff News Editor at Insurance Business Weekly ASPiRA Labs, a Vermillion company, announced it has entered into agreements with Joint Venture Hospital Laboratories, LLC, QCA Health Plan of Arkansas, Inc., Louisiana State Medicaid program, and Arizona State Medicaid Program to provide coverage for its in vitro diagnostic test, O
CONCORD- The uncertainty in the nation over the fate of CHIP, allowed to expire in September amidst uncertainty over the future of the Affordable Care Act and Medicaid, is safe in New Hampshire, at least for two years. Jake Leon, Communications Director for the New Hampshire Department of Health and Human Services, said that's because they saw the
Washington County supervisors approved a resolution at the Nov. 2 meeting to join a lawsuit against pharmaceutical companies because of the role that manufacturers such as Purdue Pharma played in the expanding the opioid epidemic affecting communities throughout the U.S.. "I will not abandon the people that I know, and that I love, who are on thes
WASHINGTON- President Donald Trump and Republican leaders in Congress have repeatedly said Obamacare is failing, or even dead. This past week in Virginia, where Democrats won a competitive race for governor, two-thirds of voters called health care a "very important" or the most important issue, according to one poll. Maine voted to expand Medicaid
Data on Science Discussed by Researchers at University of Cambridge. By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA Current study results on Science have been published. For more information on this research see: Unveiling some FDA- approved drugs as inhibitors of the store-operated Ca2+ entry pathway. Scientific Reports,
WASHINGTON- U.S. officials sent a warning to the marijuana industry, alerting online sellers they cannot market their products as a treatment for cancer. The Food and Drug Administration sent letters to four companies on Tuesday, warning them about unsubstantiated claims that their marijuana-derived products can combat tumors and kill cancer cells.
By a News Reporter-Staff News Editor at Heart Disease Weekly Research findings on Surgery- Heart Bypass Surgery are discussed in a new report. According to news originating from Nagoya, Japan, by NewsRx correspondents, research stated, "This study aimed to examine the effect of off-pump coronary artery bypass grafting in patients who underwent...
Sindh Health Department has failed to make operational' Sindh Healthcare Commission', a regulatory authority to register and monitor public and private hospitals and control quackery in the province despite the passage of four years due to financial and other problems. The Sindh Assembly passed the bill into law on 24th February 2014 and the govern
By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA New research on Clinical Research- Clinical Trials and Studies is the subject of a report. Our news editors obtained a quote from the research from Emory University, "Unfortunately, its clinical usefullness was severly limited by associated toxicities and the emergence of resi
The debate in Congress over whether to repeal and replace the Affordable Care Act has been put aside, at least for now. At Ascension Texas, comprised of Seton in Austin as well as Providence in Waco, when it comes to the challenges we face, we've seen success by segmenting those issues into their component pieces. Congress should focus on historica
States shouldn't wait for Congress to fix health care, writes Matthew Glans. Congress has failed to pass a replacement of the Patient Protection and Affordable Care Act, and Obamacare's collapse is inevitable. One of the best ways they can accomplish this is by applying for a Section 1115 waiver from the Department of Health and Human Services.
He was backed by most Republicans, and Democrats- and many elements of the medical professions- complained that care would suffer and that the contracts would not save any money. Back then, the GOP was rushing the contracts with managed care companies through, seeking a win for their governor. But GOP lawmakers raised concerns about the price tag f
Nov. 12 The Affordable Care Act is still the law of the land after multiple attempts by Congress to repeal it in recent years. The enrollment numbers only include the states that use healthcare.gov, such as Texas. Jay Claborn, a member of the Lubbock Area Association of Health Underwriters and an independent health insurance broker at The Claborn
By a News Reporter-Staff News Editor at VerticalNews Health Robot-assisted laparoscopic surgery to remove a patient's entire kidney requires slightly longer operating times and results in increased costs compared with the use of traditional laparoscopic surgery, according to a large, multiyear analysis conducted by researchers at the Stanford...
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week A patent application by the inventors LEE, Kuo-Hsiung; ZHAO, Yu; KUO, Sheng-Chu; HSU, Chung-Y.; SHYU, Woei-Cherng; CHEN, Yu-Chian; LIN, Chen-Huan; LEE, Wei; CHIANG, Chun-Wei; TSAI, Chang-Hai, filed on October 6, 2016, was made available online on October 26, 2017, according t
By a News Reporter-Staff News Editor at Investment Weekly News A patent application by the inventor SAKAI, Aiko, filed on June 20, 2017, was made available online on October 26, 2017, according to news reporting originating from Washington, D.C., by VerticalNews correspondents. This patent application is assigned to Olympus Corporation. The follo
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week A patent application by the inventors YUAN, Huixing; LI, Guotao; LIU, Jian; MA, Yaping; YUAN, Jiancheng, filed on November 26, 2015, was made available online on October 26, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This pa
The progress comes as FDA commissioner Scott Gottlieb on Thursday indicated that the agency will expand which abbreviated new drug applications will see priority reviews. The shift could accelerate generic competitors to market more quickly and help bring down costs, and comes a day after the Federal Trade Commission held a workshop on drug competi
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week Alopexx Vaccine LLC announced that it has completed a Phase 1 clinical trial with AV0328, a vaccine targeting the broadly expressed microbial antigen, poly-N-acetyl glucosamine. The World Health Organization has warned that the increasing development of numerous...
Argos Therapeutics, Inc., an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis precision immunotherapy technology platform, today provided an update on the immunology data from the February 2017 interim analysis of data from the ongoing Phase 3 ADAPT clinical trial..
By a News Reporter-Staff News Editor at Business& Finance Week ASPiRA Labs, a Vermillion company, announced it has entered into agreements with Joint Venture Hospital Laboratories, LLC, QCA Health Plan of Arkansas, Inc., Louisiana State Medicaid program, and Arizona State Medicaid Program to provide coverage for its in vitro diagnostic test, OVA1
-The Global Automated External Defibrillators Market is projected to witness significant growth during the forecast period. Automated external defibrillator is a portable, lightweight electronic instrument that automatically diagnoses cardiac arrhythmia and delivers an electric shock to restore the hearts normal rhythm. Moreover, every year, an...
Blueprint Medicines Corporation, a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced new Phase 1 clinical data for BLU-285, a potent and highly selective KIT and PDGFR inhibitor in development as a potential treatment for patients with advanced gastrointestinal stromal...
INGELHEIM AM RHEIN, Germany, Nov. 11 Boehringer Ingelheim, a pharmaceutical company, issued the following news release:. Boehringer Ingelheim and MiNA Therapeutics, a pioneer in RNA activation therapeutics, today announced that they have signed a collaboration and licensing agreement focused on the development of novel compounds to treat fibrotic
INGELHEIM AM RHEIN, Germany, Nov. 11 Boehringer Ingelheim, a pharmaceutical company, issued the following news release:. Boehringer Ingelheim and Dicerna Pharmaceuticals, a leading developer of investigational RNA interference therapeutics, today announced a research collaboration and license agreement to discover and develop novel GalXC RNAi...